Leading Hospital to Study Performance of the PreciseDx Breast Test as an Aid in the Treatment Decision Process

PreciseDx announced a collaboration with the Laboratory of Pathology at Dordrecht, Netherlands. Through this agreement, the Laboratory of Pathology will study the performance of PreciseDx’s AI-driven Cancer Risk Stratification platform, confirming its accuracy of staging and role in the decision process.